\-\ Texto\\:\\ \ \(0\)\
\-\ peripheral\\ blood\\ smear\\ had\\ elevated\\ eosinophils\\ at\\ 19\\.4\\%\\.\ \(0\)\
\-\ systemic\\ corticosteroids\\ are\\ the\\ mainstay\\ of\\ treatment\\.\\ \\ 70\\%\\ of\\ patients\\ usually\\ have\\ improvement\\ in\\ radiographic\\ findings\\ within\\ 1\\ week\\ of\\ starting\\ steroids\\.\ \(0\)\
\-\ the\\ axial\\ ct\\ images\\ show\\ primarily\\ peripheral\\ and\\ nonsegmental\\ areas\\ of\\ consolidation\\ primarily\\ involving\\ the\\ upper\\ lobes\\.\\ \\ the\\ superior\\ segments\\ of\\ the\\ lower\\ lobes\\ show\\ some\\ areas\\ of\\ peripheral\\ consolidation\\ as\\ well\\;\\ however\\,\\ the\\ basal\\ segments\\ are\\ spared\\.\\ \\ some\\ scattered\\ tree\\ and\\ bud\\ opacities\\ with\\ surrounding\\ ground\\ glass\\ opacities\\ and\\ sub\\ pleural\\ linear\\ and\\ reticular\\ opacities\\ are\\ visualized\\;\\ however\\,\\ the\\ dominant\\ pattern\\ is\\ that\\ of\\ peripheral\\ consolidation\\.\ \(0\)\
\-\ chronic\\ eosinophilic\\ pneumonia\ \(2\)\
\-\ cryptogenic\\ organizing\\ pneumonia\\ \\(cop\\,\\ boop\\)\ \(0\)\
\-\ chronic\\ eosinophilic\\ pneumonia\ \(2\)\
\-\ lipoid\\ pneumonia\ \(2\)\
\-\ bronchioloalveolar\\ cell\\ carcinoma\ \(0\)\
\-\ lymphoma\ \(373\)\
\-\ infection\\,\\ edema\\,\\ ards\\,\\ acute\\ interstitial\\ pneumonia\ \(0\)\
\-\ the\\ patient\\ presented\\ with\\ a\\ persistent\\ cough\\ and\\ chronic\\ infectious\\ symptoms\\ for\\ over\\ 5\\ months\\.\ \(0\)\
\-\ this\\ patient\\ was\\ a\\ middle\\ aged\\ female\\ who\\ presented\\ with\\ the\\ typical\\ symptoms\\ of\\ eosinophilic\\ pneumonia\\.\\ \\ the\\ peripheral\\ eosinophilia\\ and\\ radiographic\\ findings\\ further\\ supported\\ the\\ diagnosis\\ for\\ this\\ classic\\ case\\ of\\ chronic\\ eosinophilic\\ pneumonia\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ pneumonia\\:\\ 0\\.417774098741327\ \(0\)\
\-\ eosinophilic\\:\\ 0\\.29442871949122995\ \(0\)\
\-\ peripheral\\:\\ 0\\.2703505765619818\ \(0\)\
\-\ opacities\\:\\ 0\\.21657577622358115\ \(0\)\
\-\ consolidation\\:\\ 0\\.2096625334846414\ \(0\)\
\-\ chronic\\:\\ 0\\.17952863044108341\ \(0\)\
\-\ the\\:\\ 0\\.16596450049041603\ \(0\)\
\-\ segments\\:\\ 0\\.15350612980097808\ \(0\)\
\-\ primarily\\:\\ 0\\.145063653242861\ \(0\)\
\-\ of\\:\\ 0\\.13317547601119262\ \(0\)\
\-\ lobes\\:\\ 0\\.12617625878344263\ \(0\)\
\-\ nonsegmental\\:\\ 0\\.12092283858345916\ \(0\)\
\-\ radiographic\\:\\ 0\\.1121984039790504\ \(0\)\
\-\ cop\\:\\ 0\\.11173488088133365\ \(0\)\
\-\ boop\\:\\ 0\\.10877701916238273\ \(0\)\
\-\ lipoid\\:\\ 0\\.10877701916238273\ \(0\)\
\-\ cryptogenic\\:\\ 0\\.10636027016737812\ \(0\)\
\-\ bronchioloalveolar\\:\\ 0\\.10636027016737812\ \(0\)\
\-\ areas\\:\\ 0\\.10267297714789743\ \(0\)\
\-\ bud\\:\\ 0\\.10254692317920816\ \(0\)\
\-\ mainstay\\:\\ 0\\.10098565945342257\ \(0\)\
\-\ eosinophilia\\:\\ 0\\.10098565945342257\ \(0\)\
\-\ organizing\\:\\ 0\\.09958906146025723\ \(0\)\
\-\ show\\:\\ 0\\.09600268980563796\ \(0\)\
\-\ some\\:\\ 0\\.09515086256565629\ \(0\)\
\-\ ards\\:\\ 0\\.09512898030474005\ \(0\)\
\-\ and\\:\\ 0\\.09374792736654812\ \(0\)\
\-\ smear\\:\\ 0\\.09335896547708265\ \(0\)\
\-\ eosinophils\\:\\ 0\\.09335896547708265\ \(0\)\
\-\ spared\\:\\ 0\\.0897543695907845\ \(0\)\
\-\ however\\:\\ 0\\.089508992136038\ \(0\)\
\-\ supported\\:\\ 0\\.08854850037038872\ \(0\)\
\-\ presented\\:\\ 0\\.08818730576565605\ \(0\)\
\-\ reticular\\:\\ 0\\.08642309103734153\ \(0\)\
\-\ are\\:\\ 0\\.0860759314124065\ \(0\)\
\-\ starting\\:\\ 0\\.08502649304417617\ \(0\)\
\-\ symptoms\\:\\ 0\\.0827431154077566\ \(0\)\
\-\ aged\\:\\ 0\\.08260974404917157\ \(0\)\
\-\ corticosteroids\\:\\ 0\\.08189306026824432\ \(0\)\
\-\ tree\\:\\ 0\\.07965188233022062\ \(0\)\
\-\ sub\\:\\ 0\\.07675306490048904\ \(0\)\
\-\ glass\\:\\ 0\\.07606132077134546\ \(0\)\
\-\ findings\\:\\ 0\\.07463683156909257\ \(0\)\
\-\ ground\\:\\ 0\\.07360717987280749\ \(0\)\
\-\ dominant\\:\\ 0\\.07076181179377308\ \(0\)\
\-\ interstitial\\:\\ 0\\.06854743956966255\ \(0\)\
\-\ systemic\\:\\ 0\\.06709995698037194\ \(0\)\
\-\ steroids\\:\\ 0\\.06643147478351492\ \(0\)\
\-\ improvement\\:\\ 0\\.06600384347257796\ \(0\)\
\-\ scattered\\:\\ 0\\.06579509237070613\ \(0\)\
\-\ basal\\:\\ 0\\.0647022668254771\ \(0\)\
\-\ 70\\:\\ 0\\.06242933936086662\ \(0\)\
\-\ linear\\:\\ 0\\.06091278198778857\ \(0\)\
\-\ infectious\\:\\ 0\\.06084132401951725\ \(0\)\
\-\ visualized\\:\\ 0\\.059044611456726424\ \(0\)\
\-\ typical\\:\\ 0\\.0584364579666018\ \(0\)\
\-\ persistent\\:\\ 0\\.058259322755862195\ \(0\)\
\-\ pleural\\:\\ 0\\.05692150721385333\ \(0\)\
\-\ classic\\:\\ 0\\.05655545654849374\ \(0\)\
\-\ pattern\\:\\ 0\\.0564527008322714\ \(0\)\
\-\ cough\\:\\ 0\\.0564527008322714\ \(0\)\
\-\ middle\\:\\ 0\\.05407011531239636\ \(0\)\
\-\ involving\\:\\ 0\\.052963146714620955\ \(0\)\
\-\ this\\:\\ 0\\.05196448859062668\ \(0\)\
\-\ elevated\\:\\ 0\\.051546896499897785\ \(0\)\
\-\ week\\:\\ 0\\.05085814828465842\ \(0\)\
\-\ surrounding\\:\\ 0\\.050428919068709235\ \(0\)\
\-\ further\\:\\ 0\\.0492485002644763\ \(0\)\
\-\ patient\\:\\ 0\\.04918671036688552\ \(0\)\
\-\ superior\\:\\ 0\\.04915963677403623\ \(0\)\
\-\ usually\\:\\ 0\\.04760165368705288\ \(0\)\
\-\ for\\:\\ 0\\.04583589128114751\ \(0\)\
\-\ infection\\:\\ 0\\.045675076948640876\ \(0\)\
\-\ carcinoma\\:\\ 0\\.04522872430555003\ \(0\)\
\-\ edema\\:\\ 0\\.04509769766031297\ \(0\)\
\-\ lymphoma\\:\\ 0\\.04503266684625218\ \(0\)\
\-\ with\\:\\ 0\\.04441834944212512\ \(0\)\
\-\ months\\:\\ 0\\.0440133167519998\ \(0\)\
\-\ blood\\:\\ 0\\.04391357646942701\ \(0\)\
\-\ axial\\:\\ 0\\.04367721797513529\ \(0\)\
\-\ cell\\:\\ 0\\.04325454555354989\ \(0\)\
\-\ who\\:\\ 0\\.0427718018037955\ \(0\)\
\-\ patients\\:\\ 0\\.04253686658353756\ \(0\)\
\-\ over\\:\\ 0\\.04204456625249957\ \(0\)\
\-\ acute\\:\\ 0\\.04090414488948065\ \(0\)\
\-\ upper\\:\\ 0\\.0404068140224253\ \(0\)\
\-\ diagnosis\\:\\ 0\\.039197629206071165\ \(0\)\
\-\ lower\\:\\ 0\\.03863870603804426\ \(0\)\
\-\ case\\:\\ 0\\.03798752299634324\ \(0\)\
\-\ have\\:\\ 0\\.03777321290046553\ \(0\)\
\-\ had\\:\\ 0\\.037673547611293254\ \(0\)\
\-\ well\\:\\ 0\\.03661254782207973\ \(0\)\
\-\ female\\:\\ 0\\.03648711924651537\ \(0\)\
\-\ treatment\\:\\ 0\\.03601883868938709\ \(0\)\
\-\ images\\:\\ 0\\.03497639092701262\ \(0\)\
\-\ within\\:\\ 0\\.03482535904987429\ \(0\)\
\-\ that\\:\\ 0\\.03281352947114194\ \(0\)\
\-\ as\\:\\ 0\\.03037672471805013\ \(0\)\
\-\ ct\\:\\ 0\\.02878686244608433\ \(0\)\
\-\ at\\:\\ 0\\.028560268534932345\ \(0\)\
\-\ was\\:\\ 0\\.02635213856241481\ \(0\)\
\-\ is\\:\\ 0\\.020707337646134576\ \(0\)\
\-\ in\\:\\ 0\\.018810245649470505\ \(0\)\
